Research Article
IDH Mutations: Genotype-Phenotype Correlation and Prognostic Impact
Table 1
Patients demographics and clinical characteristics.
| | Glioma by grade |
| Characteristics | II () | III () | IV () | Age, years | | | | Median | 38.1 | 47.8 | 58.5 | Range | 16.1–77.0 | 19.1–89.1 | 18.2–89.1 | KPS | | | | Median | 90 | 90 | 80 | Range | 50–100 | 60–100 | 40–100 | Biopsy (%) | 25.6 | 28.7 | 26.6 | Tumor removal (%) | 74.4 | 71.3 | 73.4 | Overall survival, months | | | | Median | 121.9 | 41.7 | 14.5 | Range | 0.1–238.9 | 0.1–249.3 | 0.1–89.1 | Progression free survival, months | | | | Median | 38.8 | 19.5 | 8.2 | Range | 0.1–189.7 | 0.1–249.3 | 0.1–80.5 |
|
|
KPS: Karnofsky performance score; PFS: progression-free survival.
|